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Summary 
 
The spectrum of optic neuromyelitis ranges from monophasic or recurrent, idiopathic 
forms of the disease to optic neuromyelitis associated with autoimmune disorders. A 
distinct form of the disease called recurrent optic neuromyelitis with endocrinopathies, 
characterized by spinal cord involvement (cavitations with syringomyeloid sensory 
disturbance), rapid evolution to blindness and paraplegia, characteristic cerebrospinal 
fluid findings, and association with hypothalamus-pituitary dysfunction has recently been 
described. The first case of optic neuromyelitis with endocrinopathies in a female 
Caucasian from Europe is presented, supporting the existence of this syndrome as a 
separate entity.
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Introduction 
 
A combination of optic neuritis (ON) and acute myelitis without involvement of the brain 
is usually considered to represent optic neuromyelitis (ONM), the disease that usually 
results in paraplegia and blindness. The diagnostic criteria for ONM distinguish the 
monophasic and recurrent forms of the disease.1 In 1997, a distinct syndrome with 
clinical presentation of ON and acute myelitis, called recurrent optic neuromyelitis 
(RONM) with endocrinopathies, was first described in eight patients from French 
Antilles, and then in six patients from Brazil and one from China.2-4 We describe the first 
European case of the syndrome in a Caucasian female unrelated to the patients described 
to date.  
 
 
Case report 
 
In December 2002, a 44-year-old Caucasian female with a history of hypothyroidism and 
transitory thrombocytopenia during pregnancy developed ON on the right eye, with good 
recovery after retrobulbar corticosteroid therapy. In January 2004, she was hospitalized 
for paraplegia, sensory loss at the 8th thoracic level, and urinary and fecal incontinence. 
CSF examination revealed pleocytosis of 245/3 (180 small lymphocytes, 32 neutrophils), 
with protein level of 53 mg/100 ml. Oligoclonal IgG bands (OCB) were present in both 
CSF and serum. Viral, HIV, Borrelia burgdorferi, fungal and syphilis CSF serology and 
CSF bacterial cultures were negative, and so were immunologic tests including 
anticardiolipin antibodies, lupus anticoagulant, antinuclear antibodies and anti-dsDNA 
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antibodies. MRI was not performed on that occasion. Corticosteroid therapy (a 5-day 
course of 1000 mg metylprednisolon, followed by dose tapering) resulted in only slight 
deficit improvement. Concurrently with this bout of the disease, however before 
corticosteroid treatment was started, the patient developed hyperphagia with weight gain 
(she gained 15 kilograms), and diabetes mellitus. Thyroid hormones at this point were 
within normal limits, and antithyroid peroxidase antibody was negative. Nine months 
later she developed ON of the left eye, this time with only partial recovery. In December 
2004, she developed episode of acute, partial myelitis with left hemiparesis and ipsilateral 
temperature and pain loss in the segmental distribution of the trigeminal nerve, with 
contralateral temperature and pain loss on the body. Neurological examination revealed 
triplegia in extension, with hyperactivity of extensor reflexes and tonic extensor spasms 
of the left arm and lower limbs, with the legs in adduction and slight internal rotation. 
CSF revealed pleocytosis of 73/3 (38 small lymphocytes, 20 neutrophils and 6 
eosinophils), protein 72 mg/100 ml, and IgG index of 9.8x103. OCB were identical in 
serum and CSF, indicating that there was no intrathecal synthesis. CSF protein 
electroforesis and immunoelectroforesis were normal. Viral, HIV, Borrelia burgdorferi, 
fungal and syphilis CSF serology was negative again. At this point, immunologic testing 
revealed elevated level of anticardiolipin IgG antibodies (105 U/ml, normal value <10), 
with again negative lupus anticoagulant, antinuclear antibodies and anti-dsDNA 
antibodies. However, repeated measurement of anticardiolipin antibodies two months 
later was negative. Electromyoneurography was normal, and visual evoked potentials 
revealed wave P100 of borderline latencies with low amplitudes. On spinal cord MRI, T1 
and T2 weighted images (Figure 1A) showed a cavitation extending over the first six 
cervical vertebrae and a high signal intensity over the 3rd and 4th thoracic vertebrae on T2 
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weighted images. On transverse images, an area of high signal intensity was present in 
left lateral and dorsal columns of the cervical spine indicating involvement of left tractus 
spinalis nervi trigemini and lateral spinotalamic tract (Figure 1B). Brain MRI was normal. 
Upon treatment with corticosteroids (a 5-day course of 1000 mg metylprednisolon, 
followed by dose tapering), followed by plasmapheresis, immunoglobulin (35g/5 days) 
and cyclophosphamide (60 mg three times daily) therapy, the neurological status was 
maintained stationary.  
 
Discussion 
 
RONM with endocrinopathies has been described as being unique to black Antillean and 
Afro-Brazilian women. In the literature there are reports on only two Caucasians from 
Brazil with this syndrome associated with diabetes mellitus or amenorrhea,3 which makes 
our patient the first case of RONM with endocrinopathies described outside Brazil.   
Our patient with two bouts of ON, one of acute transverse myelitis and of partial myelitis 
each, and absence of MRI lesions in the cerebral white matter, met the diagnostic criteria 
for ONM,1 yet distinguished from ONM by several features. The first and most striking 
was the association with endocrinopathies including hypothyroidism, hyperphagia with 
obesity, and diabetes mellitus. The obesity and diabetes mellitus developed before 
introducing corticosteroid treatment, and these symptoms are very likely to be 
hypothalamic in origin. However, it is not possible to exclude the causal relationship 
between these two diseases, as type II diabetes can be a consequence of obesity. As well, 
although antithyroid peroxidase antibodies were negative, hypothyroidism was diagnosed 
15 years before development of first neurological symptoms, so it is not entirely possible 
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to exclude an autoimmune origin of this endocrinopathy. The patient also suffered from 
amenorrhea, which corresponded with the second bout of the disease, but her age and 
negative prolactin levels made this symptom questionable. The spectrum of 
endocrinopathies in RONM patients (Table 1) seems to be related to hypothalamus-
pituitary dysfunction, as gadolinium enhancement was observed in the pituitary of some 
patients from Martinique. Also, involvement of hypothalamic structures has recently been 
described in two patinents with ONM, one of which has Haitian heritage.5 These authors 
suggested that involvement of hypothalalmus should be included in diagnostic criteria for 
ONM. However we feel that hypothalamic involvement should be used as one of the 
markers (along with clinical picture, endocrinopathies and CSF findings) which 
distinguish RONM with endocrinopathies from classic ONM. It has also been shown that 
patients with so called Asian type of MS (which in fact represents RONM) may have 
elevated prolactin levels, which again implicates the involvement of hypothalamus-
pituitary level.6 Although hyperphagia with obesity and amenorrhea in our patient were 
also suggestive of a disorder at the hypothalamus-pituitary level, brain MRI was normal.   
CSF findings in patients with RONM are either normal or show pleocytosis with elevated 
protein level and negative OCB. In our patient, a characteristic finding was the presence 
of up to 41% of neutrophils in the CSF (negative CSF bacterial cultures on three 
occasions), clearly differentiating this syndrome from MS. CSF neutrophils have been 
reported in 60% of patients with recurrent ONM,1 although it does not appear to hold for 
all recurrent ONM series.7 Also, our patient showed the so-called mirror pattern, i.e. 
identical OCB in both serum and CSF, which did not indicate intrathecal synthesis.  
In patients presenting with the symptoms of either ON or transverse myelitis, 
immunologic testing is of paramount importance, since the association with some of 
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connective tissue diseases implies a different mode of treatment. ONM in the presence of 
anticardiolipin antibodies is an indication for anticoagulation therapy, although some 
authors suggest these antibodies to merely reflect polyclonal B-cell activation that is not 
organ specific.8 Nevertheless, our patient did not meet the diagnostic criteria for 
antiphospholipid syndrome,9 anticardiolipin antibodies were positive in only one 
occasion, and other characteristic antibodies for systemic lupus erythematosus and other 
connective tissue disorders and vasculitis (antinuclear antibodies, anti-dsDNA antibodies 
and lupus anticoagulant) were repeatedly negative. 
In conclusion, the patient presented had several characteristics of RONM with 
endocrinopathies: only the optic nerves and spinal cord were affected; there were no 
lesions in other parts of the central or peripheral nervous system; the clinical picture 
showed rapid evolution to triplegia and syringomyeloid sensory dissociation; endocrine 
disturbances including hypothyroidism, diabetes mellitus, hyperphagia with obesity, and 
amenorrhea; and MRI evidence of cavitations and demyelination of the cervical and 
thoracic spinal cord, without brain involvement. Although more studies are needed to 
define this disorder as a new syndrome, this case additionally supports the observation 
that RONM with endocrinopathies should be differentiated from ONM.  
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Table 1 Characteristics of patients with recurrent optic neuromyelitis with 
endocrinopathies  
Sex Ethnicity Age at first 
bout 
First 
bout 
Number 
of bouts 
Associated endocrinopathy 
Female Antillean 30 ON 3 Amenorrhea, Hypothyroidism 
Female Antillean 17 ON 7 Obesity, Amenorrhea 
Female Antillean 29 ON 4 Obesity, Amenorrhea/ Galactorrhea, 
Hypothyroidism 
Female Antillean 33 ON 4 Amenorrhea/ Galactorrhea,  
Female Antillean 27 ON 5 Obesity, Amenorrhea, Hypothyroidism 
Female Antillean 35 TM 4 Amenorrhea 
Female Antillean 53 ON 4 Hypothyroidism, Diabetes insipidus, 
Galactorrhea 
Female Antillean 28 ON 4 Amenorrhea 
Female Afro-
brazilian 
30 TM 4 Amenorrhea/ Galactorrhea 
Female Afro-
brazilian 
55 ON 13 Amenorrhea/ Galactorrhea 
Female Afro-
brazilian 
30 ON 2 Amenorrhea/ Galactorrhea 
Female Afro-
brazilian 
35 ON 8 Hypothyroidism 
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Female White-
brazilian 
44 ON 5 Diabetes mellitus 
Female White-
brazilian 
26 TM 8 Amenorrhea/ Galactorrhea 
Female Chinese 32 TM 2 Amenorrhea 
Female White 44 ON 4 Obesity, Hypothyroidism, Diabetes mellitus
ON optic neuritis; TM transverse myelitis 
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Figure 1 Magnetic resonance imaging findings: (A) T2 weighted image of the cervical 
spine showing cavitation extending over the first six vertebrae; (B) T2 weighted 
transverse image of the cervical spine showing an area of high signal intensity in the 
lateral and dorsal columns. 
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